Epigenteic Alteration of DOK7 Gene CpG Island in Blood Leukocyte of Patients with Gastric Cancer and Intestinal Methaplasia

Document Type : Brief Report

Authors

1 Department of Medical Biotechnology, Medical Genetic group, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran

2 Department of Radiation Oncology, Hamadan University of Medical Sciences, Mahdieh center, Hamadan, Iran

3 Department of Pathology, Hamadan University of Medical Sciences, Hamadan, Iran.

Abstract

Background: Intestinal metaplasia (IM) is a benign lesion with no serious concern for patients’ health. On the other 
hand, gastric cancer (GC) is a malignant lesion that has to be differentially diagnosed from benign intestinal metaplasia. 
Epigenetic modifications have been suggested to play an important role in cancer initiation and development, and they 
have been investigated as a reliable biomarker tool even for early cancer diagnosis. Whole blood leucocytes (WBC) are 
potentially the most accessible tissue for cancer early diagnosis, especially for GC, which is hard to diagnose in the early 
stage.
Objective: This study aims to investigate the methylation status of DOK7 gene CpG island in blood leukocytes of patients 
with IM and GC compared to normal control groups. 
Material and Method: DNA was extracted from the whole blood of 30 IM patients, 30 GC patients, and 34 normal 
controls samples, and MSRE-PCR was utilized to evaluate the loci methylation status.
Results: Significant hypermethylation of DOK7 gene CpG has been observed in GC 88.1 % (p < 0.001) and IM 66.0 % (p 
= 0.03) in comparison to the normal control group 56.8%. A cut‑off upper than 84.5 % of hypermethylation is considered 
as a presence of gastric cancer malignant lesions.
Conclusions: This is the first reported on hypermethylation in DOK7 CPG in blood leukocytes of patients with GC and 
IM and establishing a laboratory blood based test that may be useful as a novel biomarker test in the early diagnosis and 
screaning of GC and IM.

Keywords

Main Subjects

References

  1. References

    1. Chen K, Yang D, Li X, Sun B, Song F, Cao W, et al. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. Proc Natl Acad Sci U S A. 2015;112(4):1107-1112. doi:10.1073/pnas.1422640112
    2. Rossi F, Noren H, Jove R, Beljanski V, Grinnemo K-H. Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Research & Therapy. 2020;11(1):489. doi:10.1186/s13287-020-02018-6
    3. Heyn H, Carmona FJ, Gomez A, Ferreira HJ, Bell JT, Sayols S, et al. DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker. 2013;34(1):102-108. doi:10.1093/carcin/bgs321
    4. Pouliot M-C, Labrie Y, Diorio C, Durocher F. The Role of Methylation in Breast Cancer Susceptibility and Treatment. Anticancer Research. 2015;35(9):4569.
    5. Chen G, Yu H, Satherley L, Zabkiewicz C, Resaul J, Zhao H, et al. The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer. Oncol Rep. 2017;37(5):2695-2701. doi:10.3892/or.2017.5538
    6. Tahara T, Arisawa T.DNA methylation as a molecular biomarker in gastric cancer. 2015;7(3):475-486. doi:10.2217/epi.15.4
    7. Fitzgerald LM, Browne EP, Christie KD, Punska EC, Simmons LO, Williams KE, et al. ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors. Cancer Cell Int. 2016;16:8. doi:10.1186/s12935-016-0282-9
    8. Yang SM, Li SY, Yu HB, Li JR, Sun LL. Repression of DOK7 mediated by DNMT3A promotes the proliferation and invasion of KYSE410 and TE-12 ESCC cells. Biomed Pharmacother. 2017;90:93-99. doi:10.1016/j.biopha.2017.02.111
    9. Hua CD, Bian EB, Chen EF, Yang ZH, Tang F, Wang HL, et al. Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation. Biomed Pharmacother. 2018;106:678-685. doi:10.1016/j.biopha.2018.06.156
    10. Meyer AR, Goldenring JR. Injury, repair, inflammation and metaplasia in the stomach. J Physiol. 2018;596(17):3861-3867. doi:10.1113/JP275512
    11. Shao L, Li P, Ye J, Chen J, Han Y, Cai J, et al. Risk of gastric cancer among patients with gastric intestinal metaplasia. Int J Cancer. 2018;143(7):1671-1677. doi:10.1002/ijc.31571
    12. Boonsongserm P, Angsuwatcharakon P, Puttipanyalears C, Aporntewan C, Kongruttanachok N, Aksornkitti V, et al. Tumor‑induced DNA methylation in the white blood cells of patients with colorectal cancer. Oncol Lett. 2019;18(3):3039-3048. doi:10.3892/ol.2019.10638
    13. Ferguson Bennit HR, Gonda A, McMullen JRW, Kabagwira J, Wall NR. Peripheral Blood Cell Interactions of Cancer-Derived Exosomes Affect Immune Function. Cancer Microenviron. 2019;12(1):29-35. doi:10.1007/s12307-018-0209-1
    14. Boonsongserm P, Angsuwatcharakon P, Puttipanyalears C, Aporntewan C, Kongruttanachok N, Aksornkitti V, et al. Tumor-induced DNA methylation in the white blood cells of patients with colorectal cancer. Oncol Lett. 2019;18(3):3039-3048. doi:10.3892/ol.2019.10638
    15. Chopra-Tandon N, Wu H, Arcaro KF, Sturgeon SR. Relationships between Global DNA Methylation in Circulating White Blood Cells and Breast Cancer Risk Factors. J Cancer Epidemiol. 2017;2705860. doi:10.1155/2017/2705860

     

     

     

Iranian Journal of Biotechnology
Volume 20, Issue 2
April 2022
Pages 99-103

Files

Share

How to cite

Statistics